LRRK2 and Parkinson disease: However, some studies have suggested that early (pre-Lewy body) α-synuclein aggregates, specifically α-synuclein oligomers, contribute to neurodegeneration [193–195], and small soluble aggregates of α-synuclein have been isolated from a LRRK2 PD patient without Lewy bodies [196].